Related references
Note: Only part of the references are listed.The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms
Kosuke Mima et al.
SURGICAL ONCOLOGY-OXFORD (2017)
Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit
Jakob von Moltke et al.
NATURE (2016)
Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways
Nicholas S. Kirkby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia
Badar Mahmood et al.
BMC CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations
Andrew T. Chan et al.
GASTROENTEROLOGY (2016)
Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions
Andreas Koeberle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites
Francois Gerbe et al.
NATURE (2016)
The Role of Prostaglandin E-2 in Tumor-Associated Immunosuppression
Dingzhi Wang et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer
Katsuhiko Nosho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Aspirin and colorectal cancer: the promise of precision chemoprevention
David A. Drew et al.
NATURE REVIEWS CANCER (2016)
The aspirin-induced long non-coding RNA OLA1P2 blocks phosphorylated STAT3 homodimer formation
Haiyan Guo et al.
GENOME BIOLOGY (2016)
Excess body weight and colorectal cancer survival: the multiethnic cohort
Gertraud Maskarinec et al.
CANCER CAUSES & CONTROL (2015)
Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells
Maqbool Ahmed et al.
MOLECULAR CANCER (2015)
Estimates of benefits and harms of prophylactic use of aspirin in the general population
J. Cuzick et al.
ANNALS OF ONCOLOGY (2015)
Long-lived intestinal tuft cells serve as colon cancer-initiating cells
C. Benedikt Westphalen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Transporter function and cyclic AMP turnover in normal colonic mucosa from patients with and without colorectal neoplasia
Karen Kleberg et al.
BMC GASTROENTEROLOGY (2012)
The intestinal epithelium tuft cells: specification and function
Francois Gerbe et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Origin of the brush cell lineage in the mouse intestinal epithelium
Matthew Bjerknes et al.
DEVELOPMENTAL BIOLOGY (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Validation of Ussing Chamber Technology to Study Satiety Hormone Release From Human Duodenal Specimens
Maartje C. P. Geraedts et al.
OBESITY (2012)
Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium
Francois Gerbe et al.
JOURNAL OF CELL BIOLOGY (2011)
Regulatory mechanism of duodenal bicarbonate secretion Roles of endogenous prostaglandins and nitric oxide
Koji Takeuchi et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia
Nicolai Kaltoft et al.
BMC GASTROENTEROLOGY (2010)
The role of COX-2 in intestinal inflammation and colorectal cancer
D. Wang et al.
ONCOGENE (2010)
Prostanoids in health and disease
Emer M. Smyth et al.
JOURNAL OF LIPID RESEARCH (2009)
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prostaglandin E2 stimulates the β-catenin/T cell factor-dependent transcription in colon cancer
JY Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cyclooxygenase, lipoxygenase and tumor angiogenesis
D Nie et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Role of cyclooxygenase inhibitors for the prevention of colorectal cancer
E Stack et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2001)
Cyclooxygenase-selective inhibition of prostanoid formation:: transducing biochemical selectivity into clinical read-outs
C Patrono et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
